Data as of .
BIOY vs TECY: which paid, and which earned it?
Over the window both share BIOY paid 20.6% of its price in cash against TECY’s 17.0%, and returned more with it reinvested.
What they hold in common
By the books each fund has filed, BIOY and TECY hold 100% of their money in the same securities at the same weight.
| Holding | BIOY | TECY |
|---|---|---|
| Treasury Bill | 100.00% | 100.00% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
Performance, window by window
| Window | Total return | Cash paid | Against the benchmark | |||
|---|---|---|---|---|---|---|
| BIOY | TECY | BIOY | TECY | BIOY | TECY | |
| 3 months | +2.5% | +0.6% | 14.1% | 11.2% | −9.0 pts | +1.4 pts |
| Since launch | +2.0% | +0.9% | 20.6% | 17.0% | −15.3 pts | −13.7 pts |
| BIOY GraniteShares YieldBOOST Biotech ETF Synthetic covered call on XBI, paying weekly | TECY GraniteShares YieldBOOST Technology ETF Synthetic covered call on XLK, paying weekly | |
|---|---|---|
| Issuer | GraniteShares | GraniteShares |
| Strategy | synthetic covered call | synthetic covered call |
| Benchmark | Biotech (XBI), used as the proxy | Technology sector (XLK) |
| Pays | weekly | weekly |
| Payout rate, annualized | 60.0% | 39.0% |
| Expense ratio | 1.07% | 1.07% |
| Cash paid, 1 year | 20.6% (since launch on May 5, 2026) | 17.0% (since launch on May 5, 2026) |
| Price change, 1 year | −19.0% | −16.3% |
| Total return, 1 year | +2.0% (since launch on May 5, 2026) | +0.9% (since launch on May 5, 2026) |
| Benchmark return, 1 year | +17.3% | +14.6% |
| Ahead or behind | −15.3 pts | −13.7 pts |
| Return of capital, latest estimate | 96% | 50% |
| Age | 136 days | 136 days |
| Net assets | $1m | $1m |
BIOY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting value in cash distributions while its price fell 19.0%. With every distribution reinvested, the fund returned +2.0%. Biotech (XBI), used as the proxy returned +17.3% over the same days, so a holder was behind by 15.3 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 60.0%, paid weekly. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
TECY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, TECY paid 17.0% of its starting value in cash distributions while its price fell 16.3%. With every distribution reinvested, the fund returned +0.9%. Technology sector (XLK) returned +14.6% over the same days, so a holder was behind by 13.7 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 39.0%, paid weekly. GraniteShares estimates that 50% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
Questions people ask
- Which paid more, BIOY or TECY?
- Over the year to Sep 18, 2026, BIOY paid 20.6% of its starting price in cash and TECY paid 17.0%, so BIOY paid more. Cash paid is not the same as money made: the price change matters too.
- Which returned more once distributions are counted, BIOY or TECY?
- With every distribution reinvested, BIOY returned +2.0% and TECY returned +0.9% over the year to Sep 18, 2026, so BIOY returned more.
- Which is cheaper, BIOY or TECY?
- BIOY charges 1.07% a year and TECY charges 1.07%, so BIOY is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BIOY against TECY, data as of Sep 18, 2026. https://etfiq.com/compare/income/bioy-vs-tecy Free to use with attribution; the underlying files are at Open data.